title: New evidence for two MHC class II-restricted antigen presentation pathways by overexpression of a small G protein.
abstract: Exogenous Ags may be presented by MHC class II molecules through two distinct pathways distinguished by their sensitivity to drugs that inhibit the protein synthesis. Using this approach, we previously showed that the subunits Ig-alpha and Ig-beta, associated to B cell Ag receptor, targeted Ags either to newly synthesized or to preexisting pools of MHC class II molecules, respectively. To further characterize these two Ag presentation pathways, we altered the intra-Golgi transport of newly synthesized MHC class II by stably overexpressing, in B cells, mutants of a small G protein involved in the intra-Golgi transport, Rab6. Overexpression of GTP-bound rab6 (Q72L) mutant proteins reduced the cell surface arrival of MHC class II molecules and consequently slowed down Ag presentation dependent upon newly synthesized class II molecules. In contrast, this mutant had no effect on Ag presentation dependent upon preexisting pools of class II molecules, and the overexpression of an inactive GDP-bound form of rab6 (T27N) did not affect any Ag presentation pathway. MHC class II-restricted Ag presentation pathways can therefore be distinguished by their sensitivity to the overexpression of proteins modifying the intracellular transport of newly synthesized class II molecules.
authors.affiliation: Institut Curie, Paris, France.
authors.forename: V
authors.initials: V
authors.lastname: Briken
authors.forename: D
authors.initials: D
authors.lastname: Lankar
authors.forename: C
authors.initials: C
authors.lastname: Bonnerot
mesh_terms: D000818:Animals; D017951:Antigen Presentation / Q000235:genetics; D001692:Biological Transport / Q000276:immunology; D002352:Carrier Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D002462:Cell Membrane / Q000276:immunology / Q000378:metabolism; D019204:GTP-Binding Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology; D006056:Golgi Apparatus / Q000276:immunology / Q000378:metabolism; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis / Q000276:immunology* / Q000378:metabolism; D007700:Kinetics; D016393:Lymphoma, B-Cell; D051379:Mice; D016297:Mutagenesis, Site-Directed; D011947:Receptors, Antigen, B-Cell / Q000235:genetics / Q000378:metabolism; D017452:Receptors, IgG / Q000235:genetics / Q000378:metabolism; D011993:Recombinant Fusion Proteins / Q000378:metabolism; D014407:Tumor Cells, Cultured; D020691:rab GTP-Binding Proteins; D018631:ras Proteins / Q000096:biosynthesis* / Q000235:genetics / Q000502:physiology
chemical_list: D002352:Carrier Proteins; D000949:Histocompatibility Antigens Class II; C094135:Rab6 protein; D011947:Receptors, Antigen, B-Cell; D017452:Receptors, IgG; D011993:Recombinant Fusion Proteins; D019204:GTP-Binding Proteins; D020691:rab GTP-Binding Proteins; D018631:ras Proteins